Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Abbott's DBS System Earns Breakthrough Status for Treatment-Resistant Depression - Medical Product Outsourcing
OEM News

Abbott’s DBS System Earns Breakthrough Status for Treatment-Resistant Depression

Implanting electrodes in the brain area that regulates mood could help reduce TRD symptoms.

Abbott has obtained U.S. Food and Drug Administration (FDA) breakthrough status to investigate its deep brain stimulation (DBS) system for treatment-resistant depression (TRD).
 
Abbott’s DBS system provides personalized, adjustable therapy by implanting leads to targeted brain areas. A pulse generator implanted in the chest connected to the leads produces electrical impulses to modulate abnormal brain activity.
 
The DBS system has been previously used to control symptoms for Parkinson’s and essential tremor, but according to Abbott evidence suggests implanting electrodes in the brain area that regulates mood can help reduce TRD symptoms.
 
Certain Abbott DBS systems can be used with NeuroSphere virtual clinic, a connected care technology for communication and remote care/therapy adjustment released last year.
 
“Breakthrough product development always requires bold thinking and collaboration, and Abbott is fully committed to the journey of providing people with new therapeutic options for their treatment-resistant depression,” Pedro Malha, Abbott’s VP of neuromodulation told the press.
 
Last month at TVT: The Structural Heart Summit, Abbott also shared positive mitral and tricuspid heart valve device data for MitraClip and TriClip.

Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters